- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.10. | AstraZeneca to spend $445M to boost production of Lokelma at Texas plant | ||
| 15.10. | Real Chemistry, Publicis Health make moves to expand targeted marketing capabilities | ||
| 15.10. | GSK makes nice with antifungal partner Scynexis with $22M payment to resolve trial dispute | ||
| 15.10. | Particle Dynamics melds with former EuroAPI plant to debut new CDMO Codis | ||
| 14.10. | Cabaletta picks up the pace with new commercial chief from Legend, Celgene | ||
| 14.10. | Pfizer scores again in HER2-positive breast cancer, this time with Seagen's Tukysa | ||
| 14.10. | J&J chief Duato expects to find 'common ground' with Trump administration as industry's MFN talks play out | ||
| 14.10. | BioCryst inks $700M Astria buyout to challenge Takeda for rare disease market | ||
| 14.10. | BioNTech's African mRNA vaccine production push gets EU funding boost | ||
| 13.10. | Novo plant hit with FDA's most serious inspection classification, portending possible delays for partners | ||
| 13.10. | BMS cooks up schizophrenia stigma-busting initiative with 'Top Chef' judge Gail Simmons | ||
| 13.10. | FDA adds warning to label of J&J, Legend's Carvykti for potentially fatal intestinal disorder | ||
| 13.10. | German drug delivery specialist LTS grows US footprint with buyout of CDMO Renaissance Lakewood | ||
| 10.10. | Novo shutters cell therapy unit, ending work on potential Type 1 diabetes 'cure' | ||
| 10.10. | AstraZeneca to visit White House to formalize MFN agreement with Trump, MSNBC reports | ||
| 10.10. | Gilead's Yeztugo, Eisai's Leqembi Iqlik, Vertex's Journavx among 2025's best inventions: Time | ||
| 10.10. | Swiss auto-injector specialist Ypsomed invests $248M to build manufacturing facility in NC | ||
| 10.10. | Senate endorses Biosecure Act successor, adopting softer tone and omitting WuXi companies | ||
| 10.10. | Fierce Pharma Asia-TROP2 showdown; InnoCare, Zenas' $2B autoimmune deal; Lupin's US investment | ||
| 10.10. | Pelthos rolls out Zelsuvmi with campaign aimed at moms who 'don't mess around' | ||
| 09.10. | Planned summit hosted by DTC specialist BlinkRx raises concerns over ties to Trump admin: WSJ | ||
| 09.10. | AstraZeneca kicks off construction of $4.5B API plant in Virginia | ||
| 09.10. | Regeneron's Libtayo gains 'practice-changing' skin cancer label expansion | ||
| 09.10. | Lilly sponsors 'Project Runway' challenge to boost eczema's representation in pop culture | ||
| 09.10. | Lupin rides the onshoring wave, pledging $250M to build new respiratory production plant in Fla. |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .